Danna nan don nuna banners ɗin ku akan wannan shafin kuma ku biya kawai don nasara

Labaran Waya

Sabbin Cigaban Magunguna don Yanayin Jijiya

Written by edita

Plexium, Inc. (Plexium) da AbbVie sun shiga cikin haɗin gwiwar dabarun keɓance don haɓakawa da kuma tallata novel ɗin Magungunan Cutar Cutar Cutar Cutar (TPD) don yanayin jijiya. Wannan haɗin gwiwar ya haɗu da fa'idodin ilimin kimiyyar ƙwaƙwalwa na AbbVie tare da cikakkiyar dandamalin TPD na Plexium wanda ke ba da damar gano sabbin hanyoyin kwantar da hankali zuwa ga maƙasudin ƙalubalen magunguna na tarihi.

"Haɗin gwiwarmu tare da AbbVie yana ba mu damar ƙarfafa matsayinmu na jagoranci a cikin lalata Protein da aka yi niyya da kuma faɗaɗa mafi kyawun iyawarmu a cikin cututtukan jijiyoyin jini," in ji Shugaban Plexium & Shugaba Percival Barretto-Ko. “Kimiyyar Neuro yana daya daga cikin wuraren da ke fuskantar kalubale wajen samar da sabbin magunguna, saboda sarkakkiyar cututtukan cututtukan da ke da iyaka da hanyoyin da suka samu nasara. Tare da cikakkiyar dandamalinmu da ƙwarewar AbbVie a wannan yanki, muna cikin matsayi mai ƙarfi don gano masu lalata litattafai a kan maƙasudai masu ƙima da yawa don inganta rayuwar marasa lafiya a ƙarshe."

"Haɗin kai tare da Plexium don ganowa da ci gaba da masu lalata novel sun yi daidai da ƙoƙarin AbbVie na yin amfani da fasahar dandamali na zamani don neman ingantattun hanyoyin kwantar da hankali ga marasa lafiya da ke fama da cututtukan cututtuka masu lalata," in ji Eric Karran, Ph.D., Mataimakin Shugaban kasa, Neuroscience Discovery a AbbVie. "AbbVie ya ci gaba da mai da hankali kan tasirin canjin haƙuri da sabbin fasahohi masu ban sha'awa waɗanda zasu iya haɓaka haɓaka sabbin hanyoyin kwantar da hankali."

A karkashin sharuɗɗan haɗin gwiwar, Plexium za ta gudanar da ayyukan bincike na gaskiya don maƙasudin haɗin gwiwar, bayan haka AbbVie yana da zaɓi don zaɓar shirye-shirye don ƙarin ayyukan bincike da ci gaba. Plexium ya karɓi kuɗin kuɗi na gaba kuma ya cancanci karɓar ƙarin biyan kuɗi daga AbbVie, da kuma adadin kuɗin sarauta akan samfuran kasuwanci, kuma yana da zaɓi don shiga cikin haɓaka samfura don samun ƙarin ƙimar sarauta. AbbVie zai kasance da alhakin haɓakawa da kasuwanci a duniya na samfuran da aka samo asali daga haɗin gwiwar.

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

Share zuwa...